Starna Therapeutics, a Chinese firm focusing on the research and development of new mRNA drugs, recently announced the completion of round-A financing totaling 150...
Founded in 2019, SeaBeLife is a biotech startup developing drug candidates to block cell necrosis. Today, it’s announced a funding boost of almost €1.4 million financing from Bpifrance. SeaBeLife specialises in the development of drug candidates that block cellular necrosis in order to protect or regenerate organs affected by severe pathologies – for which there […]
